Jia Qing, Brown Michael J, Clifford Leanne, Wilson Gregory A, Truty Mark J, Stubbs James R, Schroeder Darrell R, Hanson Andrew C, Gajic Ognjen, Kor Daryl J
Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.
Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA.
Lancet Haematol. 2016 Mar;3(3):e139-48. doi: 10.1016/S2352-3026(15)00283-5. Epub 2016 Feb 18.
Perioperative haemorrhage negatively affects patient outcomes and results in substantial consumption of health-care resources. Plasma transfusions are often administered to address abnormal preoperative coagulation tests, with the hope to mitigate bleeding complications. We aimed to assess the associations between preoperative plasma transfusion and bleeding complications in patients with elevated international normalised ratio (INR) undergoing non-cardiac surgery.
We did an observational study in a consecutive sample of adult patients undergoing non-cardiac surgery with preoperative INR greater than or equal to 1·5. The exposure of interest was transfusion of preoperative plasma for elevated INR. The primary outcome was WHO grade 3 bleeding in the early perioperative period (from entry into the operating room until 24 h following exit from operating room). Hypotheses were tested with univariate and propensity-matched analyses. We did multiple sensitivity analyses to further evaluate the robustness of study findings.
Between Jan 1, 2008, and Dec 31, 2011, we identified 1234 (8·4%) of 14 743 patients who had an INR of 1·5 or above and were included in this investigation. Of 1234 study participants, 139 (11%) received a preoperative plasma transfusion. WHO grade 3 bleeding occurred in 73 (53%) of 139 patients who received preoperative plasma compared with 350 (32%) of 1095 patients who did not (odds ratio [OR] 2·35, 95% CI 1·65-3·36; p<0·0001). Among the propensity-matched cohort, 65 (52%) of 125 plasma recipients had WHO grade 3 bleeding compared with 97 (40%) of 242 of those who did not receive preoperative plasma (OR 1·75, 95% CI 1·09-2·81; p=0·021). Results from multiple sensitivity analyses were qualitatively similar.
Preoperative plasma transfusion for elevated international normalised ratios was associated with an increased frequency of perioperative bleeding complications. Findings were robust in the sensitivity analyses, suggestive that more conservative management of abnormal preoperative international normalised ratios is warranted.
Mayo Clinic, National Institutes of Health.
围手术期出血会对患者预后产生负面影响,并导致大量医疗资源的消耗。血浆输注常用于纠正术前异常的凝血检查结果,以期减少出血并发症。我们旨在评估在国际标准化比值(INR)升高的非心脏手术患者中,术前血浆输注与出血并发症之间的关联。
我们对连续入选的术前INR大于或等于1.5的成年非心脏手术患者进行了一项观察性研究。感兴趣的暴露因素是因INR升高而进行的术前血浆输注。主要结局是围手术期早期(从进入手术室至离开手术室后24小时)的WHO 3级出血。通过单因素分析和倾向评分匹配分析对假设进行检验。我们进行了多项敏感性分析,以进一步评估研究结果的稳健性。
在2008年1月1日至2011年12月31日期间,我们在14743例患者中确定了1234例(8.4%)INR为1.5或以上并纳入本研究。在1234例研究参与者中,139例(11%)接受了术前血浆输注。接受术前血浆输注的139例患者中有73例(53%)发生了WHO 3级出血,而未接受术前血浆输注的1095例患者中有350例(32%)发生了WHO 3级出血(比值比[OR]2.35,95%CI 1.65 - 3.36;p<0.0001)。在倾向评分匹配队列中,125例血浆接受者中有65例(52%)发生了WHO 3级出血,而未接受术前血浆输注的242例患者中有97例(40%)发生了WHO 3级出血(OR 1.75,95%CI 1.09 - 2.81;p = 0.021)。多项敏感性分析的结果在定性上相似。
因国际标准化比值升高而进行术前血浆输注与围手术期出血并发症发生率增加相关。敏感性分析结果稳健,提示对于术前国际标准化比值异常应采取更保守的管理措施。
梅奥诊所、美国国立卫生研究院。